TY  - GEN
AU  - Ringe,J D
AU  - Dorst,A
AU  - Faber,H
AU  - Ibach,K
AU  - Preuss,J
TI  - Three-monthly ibandronate bolus injection offers favourable tolerability and sustained efficacy advantage over two years in established corticosteroid-induced osteoporosis
SN  - 1462-0324
PY  - 2003///0718
KW  - Aged
KW  - Back Pain
KW  - drug therapy
KW  - Bone Density
KW  - drug effects
KW  - Calcaneus
KW  - physiopathology
KW  - Diphosphonates
KW  - administration & dosage
KW  - Drug Administration Schedule
KW  - Female
KW  - Femur Neck
KW  - Glucocorticoids
KW  - adverse effects
KW  - Humans
KW  - Hydroxycholecalciferols
KW  - therapeutic use
KW  - Ibandronic Acid
KW  - Injections, Intravenous
KW  - Lumbar Vertebrae
KW  - Male
KW  - Middle Aged
KW  - Osteoporosis
KW  - chemically induced
KW  - Prospective Studies
KW  - Spinal Fractures
KW  - prevention & control
N1  - Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
UR  - https://doi.org/10.1093/rheumatology/keg205
ER  -